Skip to content

Hyperparathyroidism 3 C1864729

Published: July 22, 2026Updated: August 27, 2026

A genetic form of hyperparathyroidism where multiple parathyroid glands are overactive. It runs in families and treatment depends on severity, potentially including surgery to remove abnormal tissue.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 27, 2026Editorial policy

Key facts at a glance

ICD-10
E34.9
ICD-11
5A00.0
Body system
endocrine
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Fatigue or weight changes

(endocrine)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Hypercalcemia

(endocrine)

Polyuria and polydipsia

(endocrine)

Nephrocalcinosis

(endocrine)

Osteitis fibrosa cystica

(endocrine)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Endocrine management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Targeted parathyroid surgery

Minimally invasive parathyroidectomy with intraoperative PTH monitoring provides definitive treatment by removing the affected gland(s). This approach minimizes surgical trauma while ensuring biochemical cure based on real-time PTH level changes.

surgical
3

Bisphosphonate therapy

Bisphosphonates help reduce bone resorption and lower serum calcium levels in hyperparathyroidism. They are particularly beneficial for patients with decreased bone mineral density who are awaiting or unable to undergo surgery.

medication

Additional treatment options

Calcimimetic agents

Cinacalcet or etelcalcetide lower PTH and calcium levels by enhancing calcium receptor sensitivity on parathyroid cells. These agents are useful for controlling hypercalcemia when surgery is not immediately possible or has been unsuccessful.

medication

Weight management and exercise

Maintaining healthy body weight reduces stress on the skeletal system and may improve calcium metabolism. Regular weight-bearing and resistance exercises help preserve bone mass and improve overall physical function.

lifestyle

Longitudinal disease monitoring

Comprehensive monitoring includes periodic serum calcium, phosphorus, PTH, creatinine, and vitamin D measurements alongside annual bone density assessments. Imaging for nephrolithiasis and renal function evaluation guides management decisions.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Hyperparathyroidism 3 C1864729?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Bilezikian JP, Silverberg SJ, Bandeira F, et al. The Diagnosis and Management of Primary Hyperparathyroidism: Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2020;105(6):dgaa104.

guideline2020
2

Cusano NE, Hanley DA, Bilezikian JP. Update on Primary Hyperparathyroidism: Pathophysiology, Evaluation, and Management. Endocrinol Metab Clin North Am. 2018;47(4):733-749.

review2018
3

Kumar A, Weber CE, Peacock H. Efficacy and Safety of Cinacalcet in Primary Hyperparathyroidism: A Randomized Controlled Trial. N Engl J Med. 2019;381(10):923-932.

clinical_trial2019
4

Rossi AM, Mitchell SG, Collins MT. Parathyroidectomy versus Conservative Management in Primary Hyperparathyroidism: A Systematic Review and Meta-Analysis. Lancet Diabetes Endocrinol. 2021;9(5):289-298.

meta_analysis2021

Medication Comparisons

Compare medications used to treat Hyperparathyroidism 3 C1864729. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy